PT3075738T - Derivado de ácido glicirretínico e utilização do mesmo - Google Patents

Derivado de ácido glicirretínico e utilização do mesmo

Info

Publication number
PT3075738T
PT3075738T PT14864563T PT14864563T PT3075738T PT 3075738 T PT3075738 T PT 3075738T PT 14864563 T PT14864563 T PT 14864563T PT 14864563 T PT14864563 T PT 14864563T PT 3075738 T PT3075738 T PT 3075738T
Authority
PT
Portugal
Prior art keywords
acid derivative
glycyrrhetinic acid
glycyrrhetinic
derivative
acid
Prior art date
Application number
PT14864563T
Other languages
English (en)
Inventor
Hideyuki C/O Department Of Neurology And Stroke Medicine Yokohama City University Takeuchi
Akio C/O Ini Corporation Suzumura
Original Assignee
Ini Corp
Takeuchi Hideyuki Department Of Neurology And Stroke Medicine Yokohama City Univ Graduate School Of
Suzumura Akio Ini Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ini Corp, Takeuchi Hideyuki Department Of Neurology And Stroke Medicine Yokohama City Univ Graduate School Of, Suzumura Akio Ini Corp filed Critical Ini Corp
Publication of PT3075738T publication Critical patent/PT3075738T/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Psychology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT14864563T 2013-11-25 2014-11-20 Derivado de ácido glicirretínico e utilização do mesmo PT3075738T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2013243130 2013-11-25

Publications (1)

Publication Number Publication Date
PT3075738T true PT3075738T (pt) 2019-04-30

Family

ID=53179585

Family Applications (1)

Application Number Title Priority Date Filing Date
PT14864563T PT3075738T (pt) 2013-11-25 2014-11-20 Derivado de ácido glicirretínico e utilização do mesmo

Country Status (11)

Country Link
US (1) US9796751B2 (pt)
EP (1) EP3075738B1 (pt)
JP (1) JP6227665B2 (pt)
CA (1) CA2931492C (pt)
DK (1) DK3075738T3 (pt)
ES (1) ES2719330T3 (pt)
HU (1) HUE042429T2 (pt)
PL (1) PL3075738T3 (pt)
PT (1) PT3075738T (pt)
TR (1) TR201902205T4 (pt)
WO (1) WO2015076325A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2946188T3 (es) 2016-11-09 2023-07-13 Univ Osaka Procedimiento para modificar una población de linfocitos T
WO2025023160A1 (ja) * 2023-07-21 2025-01-30 宏輝システムズ株式会社 認知症の治療又は予防に用いるための組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100488979C (zh) 2005-10-14 2009-05-20 天津药物研究院 甘草次酸-30-酰胺类衍生物及其用途
US20090304712A1 (en) 2006-02-02 2009-12-10 National University Corporation Nagoya University Neuronal Cell Death Inhibitor and Screening Method
US8378112B2 (en) * 2008-07-16 2013-02-19 Ini Corporation Glycyrrhetinic acid derivative and use thereof
EP2228380A1 (en) 2009-03-13 2010-09-15 onepharm Research & Development GmbH Novel triterpene derivatives
US9457030B2 (en) * 2012-10-29 2016-10-04 Board Of Regents Of The University Of Nebraska Compositions and methods for the treatment of juvenile neuronal ceroid lipofuscinosis and related disorders

Also Published As

Publication number Publication date
CA2931492C (en) 2020-03-24
US20160376303A1 (en) 2016-12-29
EP3075738A4 (en) 2017-10-11
TR201902205T4 (tr) 2019-03-21
JP6227665B2 (ja) 2017-11-08
CA2931492A1 (en) 2015-05-28
JPWO2015076325A1 (ja) 2017-03-16
EP3075738A1 (en) 2016-10-05
HUE042429T2 (hu) 2019-06-28
WO2015076325A1 (ja) 2015-05-28
ES2719330T3 (es) 2019-07-09
DK3075738T3 (en) 2019-04-23
PL3075738T3 (pl) 2019-09-30
EP3075738B1 (en) 2019-02-13
US9796751B2 (en) 2017-10-24

Similar Documents

Publication Publication Date Title
GB2535911B (en) Strigolactone formulations and uses thereof
EP2941246A4 (en) BORONIC ACID DERIVATIVES AND THEIR THERAPEUTIC USES
EP2828258A4 (en) NOVEL PYRIDOPYRIMIDINE DERIVATIVES AND THEIR USE
SG11201507327TA (en) Pyrazole-amide compound and medicinal uses therefor
SG11201506713TA (en) 2-acylaminothiazole derivative and salt thereof
IL244214B (en) Thienopiperidine derivative and its use
ZA201405392B (en) Substituted phenylimidazopyrazoles and use thereof
ZA201601880B (en) Hetero-transglycosylase and uses thereof
IL240177A0 (en) Converted chromium-6-yloxy-cycloalkanes and their use as drugs
PL3075738T3 (pl) Pochodna kwasu glicyretynowego i jej zastosowanie
GB201305297D0 (en) Novel agents and uses thereof
GB201301772D0 (en) Fastener
IL240447A (en) Propionic Acid-Baryl Acid Derivatives and Their Use as Pharmaceutical Preparations
EP3050893A4 (en) Glycoamino acid and use thereof
IL240422A0 (en) Bi-aryl derivatives of propionic acid and their use as medicinal preparations
GB201313605D0 (en) Novel compounds and their use
IL227381A0 (en) A towel and a clamp
GB201301393D0 (en) Kiddibidet and pottibidet
GB201309338D0 (en) Fastener